You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

PEMETREXED DISODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pemetrexed Disodium patents expire, and when can generic versions of Pemetrexed Disodium launch?

Pemetrexed Disodium is a drug marketed by Accord Hlthcare, Amneal, Apotex, Baxter Hlthcare Corp, Biocon Pharma, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Meitheal, Mylan Labs Ltd, Nang Kuang Pharm Co, Prinston Inc, Qilu Pharm Hainan, Waverley Pharma Inc, Zydus Pharms, and Sandoz. and is included in twenty-two NDAs.

The generic ingredient in PEMETREXED DISODIUM is pemetrexed disodium. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the pemetrexed disodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pemetrexed Disodium

A generic version of PEMETREXED DISODIUM was approved as pemetrexed disodium by ACCORD HLTHCARE on May 25th, 2022.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PEMETREXED DISODIUM?
  • What are the global sales for PEMETREXED DISODIUM?
  • What is Average Wholesale Price for PEMETREXED DISODIUM?
Drug patent expirations by year for PEMETREXED DISODIUM
Recent Clinical Trials for PEMETREXED DISODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme Corp.Phase 3
Guangdong Association of Clinical TrialsPhase 3
Tianjin Medical University Cancer Institute and HospitalPhase 2

See all PEMETREXED DISODIUM clinical trials

Pharmacology for PEMETREXED DISODIUM
Medical Subject Heading (MeSH) Categories for PEMETREXED DISODIUM
Anatomical Therapeutic Chemical (ATC) Classes for PEMETREXED DISODIUM
Paragraph IV (Patent) Challenges for PEMETREXED DISODIUM
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ALIMTA For Injection pemetrexed disodium 750 mg/vial 021462 1 2016-10-06
ALIMTA For Injection pemetrexed disodium 1000 mg/vial 021462 1 2012-06-27
ALIMTA For Injection pemetrexed disodium 100 mg/vial 021462 1 2008-07-01
ALIMTA For Injection pemetrexed disodium 500 mg/vial 021462 2 2008-02-04

US Patents and Regulatory Information for PEMETREXED DISODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms PEMETREXED DISODIUM pemetrexed disodium POWDER;INTRAVENOUS 214073-001 May 25, 2022 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Labs Ltd PEMETREXED DISODIUM pemetrexed disodium POWDER;INTRAVENOUS 203628-001 Mar 10, 2023 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira PEMETREXED DISODIUM pemetrexed disodium SOLUTION;INTRAVENOUS 214218-002 Jun 22, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare PEMETREXED DISODIUM pemetrexed disodium SOLUTION;INTRAVENOUS 214408-002 Jul 19, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz PEMETREXED DISODIUM pemetrexed disodium SOLUTION;INTRAVENOUS 214657-003 May 26, 2022 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.